Literature DB >> 8298940

Change towards earlier stage at presentation of colorectal cancer.

M H Robinson1, W M Thomas, J D Hardcastle, J Chamberlain, C M Mangham.   

Abstract

A study was carried out to investigate the change in stage at presentation of patients with colorectal cancer over 10 years. Cases were identified from the control group of subjects enrolled into a randomized controlled study based on Haemoccult screening for colorectal neoplasia. Of 405 subjects in the control group (presenting with symptomatic colorectal cancer, 206 presented before 1989 and 199 since then. The number of patients with Dukes' stage A carcinoma diagnosed since 1989 rose from 21 (10.4 per cent) to 35 (18.1 per cent); this change occurred for rectosigmoid tumours (9.9 per cent before 1989, 28 per cent after 1989) but not for colonic cancer (10.9 per cent before 1989, 11.5 per cent thereafter). An increase in the proportion of patients with symptomatic early-stage rectosigmoid cancer has been observed in the past 10 years. No such change occurred in those with colonic cancer. This may reflect a change in awareness of te disease and its symptoms by patients and general practitioners.

Entities:  

Mesh:

Year:  1993        PMID: 8298940     DOI: 10.1002/bjs.1800801241

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Management of colorectal cancer.

Authors:  A Melville; T A Sheldon; R Gray; A Sowden
Journal:  Qual Health Care       Date:  1998-06

2.  Interval cancers in a national colorectal cancer screening programme.

Authors:  Robert Jc Steele; Greig Stanners; Jaroslaw Lang; David H Brewster; Francis A Carey; Callum G Fraser
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

3.  Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.

Authors:  Sharmeela Kaushal; Michele K McElroy; George A Luiken; Mark A Talamini; A R Moossa; Robert M Hoffman; Michael Bouvet
Journal:  J Gastrointest Surg       Date:  2008-07-30       Impact factor: 3.452

4.  Establishing cancer units.

Authors:  R A Haward
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.